FDA Inspection
TCA Cellular Therapy, LLCTCA Cellular Therapy, LLC – FDA Inspection, Mar 31, 2011
Record Details
This FDA Inspection record concerns TCA Cellular Therapy, LLC, with an inspection on March 31, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- TCA Cellular Therapy, LLC
- Inspection Date
- March 31, 2011
- Product Type
- Biologics
View Company Profile
ID · ab27afec-db5a-4358-a764-09b88073c28b
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 720021
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
37- 21 CFR 1271.85(b)(2)SOP for release; reactive for CMV
- 21 CFR 211.188(b)(9)Description of containers and closures
- 21 CFR 211.188(b)(6)Inspection of packaging and labeling area
- 21 CFR 211.188(b)(11)Identification of persons involved, each significant step
- 21 CFR 211.188(b)(2)Identity of major equipment and lines used
- 21 CFR 211.188(b)(3)Identification of each component or in-process material
- 21 CFR 312.8(a)(3)Charging for Investigational Drugs Under IND
- 21 CFR 211.100(b)Procedure Deviations Recorded and Justified
- 21 CFR 1271.55(d)(1)(iii)Documentation--determination, by whom, date
- 21 CFR 1271.75(b)Risk factors, leukocyte-rich cells or tissues
Showing 10 of 37 citations.
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.